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G. Chad Hughes, MD, Jeffrey J. Nienaber, MD, Errol L. Bush, MD, Mani A. Daneshmand, MD,
and Richard L. McCann, MD, Durham, NC
This report describes our experience with ‘‘hybrid’’ aortic arch and thoracoabdominal debranching
using custom fabricated Dacron branch grafts with a single inflow source combined with
endovascular aneurysm exclusion. Our results indicate this technique, which avoids the need for CPB
and aortic crossclamping, may be a safe alternative to conventional open repair for thoracoabdominal
and arch aneurysms in selected high-risk patients. Longer term follow-up is needed to determine the
durability of this approach.
29 Incomplete revascularization reduces survival benefit of coronary artery bypass
grafting: Role of off-pump surgery
Mats J. Synnergren, MD, PhD, Rolf Ekroth, MD, PhD, Anders Ode´n, PhD, Helena Rexius, MD, PhD,
and Lars Wiklund, MD, PhD
Completeness of revascularization was found to be a determinant of long-term survival after CABG
in a retrospection study of 9408 patients using a multivariate poisson regression model.
(continued on page 14A)
The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 13A
ED
ITO
RIA
L
A
CD
CH
D
CSP
ET
G
TS37 A self-renewing, tissue-engineered vascular graft for arterial reconstruction
Kei Torikai, MD, Hajime Ichikawa, MD, PhD, Koichiro Hirakawa, MS, Goro Matsumiya, MD, PhD,
Toru Kuratani, MD, PhD, Shigemitsu Iwai, MD, PhD, Atsuhiro Saito, PhD,
Naomasa Kawaguchi, PhD, Nariaki Matsuura, MD, PhD, and Yoshiki Sawa, MD, PhD, Osaka, Japan
The authors focused on the concept of in situ cellularization and developed a tissue-engineered
vascular graft for arterial reconstruction that would facilitate renewal of autologous tissue without any
pretreatment.
46 Stress cardiac single-photon emission computed tomographic imaging late after
coronary artery bypass surgery for risk stratification and estimation of time to
cardiac events
Wanda Acampa, MD, PhD, Mario Petretta, MD, Laura Evangelista, MD, Gianantonio Nappi, MD,
Luca Luongo, MD, Maria Piera Petretta, MD, and Alberto Cuocolo, MD, Naples, Italy
Stress cardiac tomography 5 years after coronary artery bypass grafting is useful to characterize the
risk of cardiac events and its temporal variation
52 Deleterious outcome of No-React–treated stentless valved conduits after aortic
root replacement: Why were Warnings ignored?
Thierry P. Carrel, MD, Florian S. Schoenhoff, MD, Juerg Schmidli, MD, Mario Stalder, MD,
Friedrich S. Eckstein, MD, and Lars Englberger, MD, Berne, Switzerland
The use of the shell high aortic stentless conduit can no longer be advocated, and meticulous follow-
up of patients in whom this device has been implanted has to be recommended.
58 Spironolactone alleviates late cardiac remodeling after left ventricular
restoration surgery
Masaki Tsukashita, MD, Akira Marui, MD, PhD, Takeshi Nishina, MD, PhD, Eiji Yoshikawa, MD,
Hideo Kanemitsu, MD, PhD, Jian Wang, MD, Tadashi Ikeda, MD, PhD, and Masashi Komeda, MD,
PhD, Kyoto and Shizuoka, Japan
Spironolactone alleviated cardiac remodeling and redilation late after left ventricular restoration
surgery without inducing hypotension. It may be a possible therapeutic option after LVR and may
improve LV function and long-term mortality and morbidity.
65 A proteomic study of the aortic media in human thoracic aortic dissection:
Implication for oxidative stress
Mingfang Liao, MD, PhD, Zhaoyang Liu, PhD, Junmin Bao, MD, Zhiqing Zhao, MD, Jianwen Hu,
PhD, Xiang Feng, MD, Rui Feng, MD, Qingsheng Lu, MD, Zhijun Mei, MD, Yanling Liu, MS,
Qingyu Wu, MD, PhD, and Zaiping Jing, MD, Shanghai, China and Ohio
We analyzed the differentially expressed proteins of the aortic media from thoracic aortic dissection
and normal controls by comparative proteomics, which may provide important insights into the
molecular mechanisms of the disease. Our results also suggest that increased oxidative stress may
contribute to the pathogenesis of thoracic aortic dissection.
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P. M. McCarthy, MD, E. C. McGee, MD, V. H. Rigolin, MD, Q. Zhao, MD, H. Subacius, MA,
A. L. Huskin, RN, S. Underwood, RN, B. J. Kane, RDCS, I. Mikati, MD, G. Gang, MD, and
R. O. Bonow, MD, Chicago, Ill
The Myxo-ETlogix mitral valve ring (Edwards Lifesciences LLC, Irvine, Calif) was specifically
designed for patients with myxomatous disease. In initial clinical experience, nonobstructive systolic
anterior motion was rare and obstructive systolic anterior motion not observed. Ongoing prospective
echocardiographic and clinical studies will elucidate the role of this etiology-specific ring.
82 Clinical outcomes of combined aortic root replacement with mitral valve
surgery
Tirone E. David, MD, Susan Armstrong, MSc, Manjula Maganti, MSc, and Leo Ihlberg, MD,
Toronto, Ontario, Canada
A retrospective review of 123 patients who underwent combined aortic root replacement with mitral
valve surgery revealed an operative mortality of 6.5%. The survival at 10 years was 79.3% 6 4.9%,
and the freedom from reoperation was 85.7% 6 6.4%.
Surgery for Congenital
Heart Disease (CHD)
88 Extubation in the operating room after congenital heart surgery in children
Alexander J. C. Mittnacht, MD, Maria Thanjan, MD, Shubhika Srivastava, MD, Umesh Joashi, MD,
Carol Bodian, PhD, Sabera Hossain, MS, Nobuhide Kin, MD, Ingrid Hollinger, MD,
and Khanh Nguyen, MD, New York, NY and Tokyo, Japan
In this retrospective analysis, younger age, longer cardiopulmonary bypass time, male gender, and
high inotrope requirement were independently associated with not extubating in the operating room
after congenital heart surgery in children aged more than 1 month.
94 Risk factors for interstage death after stage 1 reconstruction of hypoplastic left
heart syndrome and variants
David A. Hehir, MD, Troy E. Dominguez, MD, Jean A. Ballweg, MD, Chitra Ravishankar, MD,
Bradley S. Marino, MD, MPP, MSCE, Geoffrey L. Bird, MD, Susan C. Nicolson, MD,
Thomas L. Spray, MD, J. William Gaynor, MD, and Sarah Tabbutt, MD, PhD, Philadelphia, Pa
From January 1998 to April 2005, 368 neonates with HLHS and its variants underwent stage 1
reconstruction. Of the 313 patients surviving to discharge, 33 (10.5%) suffered an interstage death.
Intact atrial septum and older age at time of surgery are risk factors for interstage death.
100 Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients
6 to 18 years of age
Andrew D. Blaufox, MD, Lynn A. Sleeper, ScD, David J. Bradley, MD, Roger E. Breitbart, MD, Allan
Hordof, MD, Ronald J. Kanter, MD, Elizabeth A. Stephenson, MD, Mario Stylianou, PhD, Victoria L.
Vetter, MD, and J. Philip Saul, MD, Charleston, SC; Watertown and Boston, Mass; Salt Lake City,
Utah; New York, NY; Durham, NC; Ontario, Canada; Bethesda, Md; and Philadelphia, Pa
The National Heart, Lung, and Blood Institute Pediatric Heart Network conducted a cross-sectional
analysis of heart rate and rhythm abnormalities in Fontan patients. A lower resting heart rate and
a higher peak heart rate are each independently weakly associated with better physical function as
measured by anaerobic threshold and Child Health scores.
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Soo-Jin Kim, MD, PhD, Woong-Han Kim, MD, PhD, Hong-Gook Lim, MD, and Jae-Young Lee, MD,
Bucheon, and Seoul, Korea
Between 1996 and 2006, 200 patients had the extracardiac conduit Fontan operation. At 10-year
follow-up, survival was 92.4%6 2.1%, freedom from reoperation was 82.4%6 4.1%, and freedom
from arrhythmia was 85.1%6 4.4%. This study showed that during 10 years of follow-up, the results
after an extracardiac Fontan procedure were satisfactory.
117 The endothelin-1 G5665T polymorphism impacts transplant-free survival for
single ventricle patients
Paul M. Kirshbom, MD, William T. Mahle, MD, Ronald W. Joyner, MD, PhD, Traci Leong, PhD,
Malania Wilson, MS, Brian E. Kogon, MD, Kirk R. Kanter, MD, and Mark M. Bouzyk, PhD,
Atlanta, Ga
We investigated the effect of the endothelin-1 G5665T single nucleotide polymorphism on
transplant-free survival in palliated single-ventricle patients. Patients homozygous for the T allele had
significantly worse transplant-free survival. The association was strongest for patients with
hypoplastic left heart syndrome.
123 Significant correlation of comprehensive Aristotle score with total cardiac
output during the early postoperative period after the Norwood procedure
Jia Li, MD, PhD, Gencheng Zhang, MD, PhD, Helen Holtby, MD, Sally Cai, MS, Mark Walsh, MD,
Christopher A. Caldarone, MD, and Glen S. Van Arsdell, MD, Toronto, Ontario, Canada
Comprehensive Aristotle score significantly and negatively correlates with CO after the Norwood
procedure. A preoperative estimation of the comprehensive Aristotle score, particularly in association
with myocardial dysfunction, mechanical ventilation to treat cardiorespiratory failure,
atrioventricular valve regurgitation and aortic atresia helps to anticipate a high risk of low cardiac
output syndrome.
Cardiopulmonary
Support and Physiology
(CSP)
129 Impaired sublingual microvascular perfusion during surgery with
cardiopulmonary bypass: A pilot study
Corstiaan A. den Uil, MD, Wim K. Lagrand, MD, PhD, Peter E. Spronk, MD, PhD, Ron T. van
Domburg, PhD, Jan Hofland, MD, PhD, Christian Lu¨then, MD, Jasper J. Brugts, MD, MSc, Martin
van der Ent, MD, PhD, and Maarten L. Simoons, MD, PhD, Rotterdam, Apeldoorn and Amsterdam,
The Netherlands
We observed sublingual microvascular blood flow during coronary artery bypass grafting.
Microcirculatory blood flow decreased in the cardiopulmonary bypass period, irrespective of
systemic blood pressure.
135 Pretreatment with u-3 fatty acid infusion to prevent leukocyte–endothelial
injury responses seen in cardiac surgery
Jonathan McGuinness, MD, PhD, John Byrne, MB, BCH, BAO, MRCSI, Claire Condron, PhD, Jim
McCarthy, MCh, FRCSI, David Bouchier-Hayes, MCh, FRCSI, and J. Mark Redmond, MD, Dublin,
Ireland
Pretreatment with u-3 infusion for 4 hours attenuates key components of leukocyte and endothelial
activation that result in excessive perioperative organ leukosequestration, a key inducer of organ
dysfunction after cardiac surgery. The inhibitory effects of pretreatment are mediated at transcription
level, possibly through enhanced heat shock protein 72 expression.
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TS142 Atrial natriuretic peptide gene transfection with a novel envelope vector system
ameliorates pulmonary hypertension in rats
Yoshihide Mitani, MD, PhD, Junko Maruyama, MD, PhD, Bao Hua Jiang, MD, PhD, Hirofumi
Sawada, MD, PhD, Hideto Shimpo, MD, PhD, Kyoko Imanaka–Yoshida, MD, PhD, Yasufumi
Kaneda, MD, PhD, Yoshihiro Komada, MD, PhD, and Kazuo Maruyama, MD, PhD, Tsu,
Mie and Suita, Osaka, Japan
A novel HVJ-envelope vector, in which DNA is incorporated into an inactivated viral particle
deprived of its genome, was recently developed as a ready-to-use vector for gene therapy.
Intratracheal atrial natriuretic peptide gene transfer by using this vector is an efficient, relatively safe,
and ready-to-use gene transfer approach for pulmonary vascular diseases.
150 Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local
Renin–Angiotensin System
Chiyo Ootaki, MD, Michifumi Yamashita, MD, PhD, Yoshio Ootaki, MD, PhD, Keiji Kamohara,
MD, Stephan Weber, Dipl Ing, Ryan S. Klatte, BSBME, William A. Smith, DEng, PE,
Alex L. Massiello, MEBME, Steven N. Emancipator, MD, Leonard A. R. Golding, MD,
and Kiyotaka Fukamachi, MD, PhD, Cleveland, Ohio
We compared histologic changes in calf renal arteries subjected to various degrees of pulsatile
circulation; continuous flow LVAD, continuous flow RVAD, pulsatile TAH, and control. We
observed severe periarteritis and up-regulation of local renin–angiotensin system only in the LVAD
group.
159 Vascular allografts are resistant to methicillin-resistant Staphylococcus aureus
through indoleamine 2,3-dioxygenase in a murine model
A. Saito, MD, PhD, N. Motomura, MD, PhD, K. Kakimi, MD, PhD, K. Narui, PhD, N. Noguchi, PhD,
M. Sasatsu, PhD, K. Kubo, MSc, Y. Koezuka, PhD, D. Takai, MD, PhD, S. Ueha, PhD,
and S. Takamoto, MD, PhD, Tokyo, Japan
Rat vascular allografts suppressed methicillin-resistant Staphylococcus aureus proliferation.
Indoleamine-2,3-dioxygenase, which is a tryptophan-metabolizing enzyme induced by interferon g
stimulation after allogeneic transplantation, contributed to this mechanism by producing
3-hydroxykynurenine, which acted as a local antimicrobial agent.
Evolving Technology (ET) 168 A dynamic and chamber-specific mitochondrial remodeling in right ventricular
hypertrophy can be therapeutically targeted
Jayan Nagendran, MD, Vikram Gurtu, BSc, David Z. Fu, BSc, Jason R. B. Dyck, PhD, Al Haromy,
BSc, David B. Ross, MD, Ivan M. Rebeyka, MD, and Evangelos D. Michelakis, MD, Edmonton,
Alberta, Canada
The RV fails quickly after increases in its afterload. We show that the poor performance of the
hypertrophied RV is caused, at least in part, by a suboptimal mitochondrial/metabolic remodeling
during hypertrophy. This can be pharmacologically reversed by metabolic modulators
(dichloroacetate) and is associated with improved contractility.
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179 Accelerated treatment of postpneumonectomy empyema: A binational long-
term study
Didier Schneiter, MD, Tomasz Grodzki, MD, Didier Lardinois, MD, Peter B. Kestenholz, MD,
Janusz Wojcik, MD, Bartosz Kubisa, MD, Jaroslaw Pierog, MD, and Walter Weder, MD, Zurich,
Switzerland and Szczecin Zdunowo, Poland
Treatment of postpneumonectomy empyema with the accelerated treatment is effective and safe.
186 Rigid bronchoscopy and surgical resection for broncholithiasis and calcified
mediastinal lymph nodes
Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD, and Lee Maniscalco, BS,
Birmingham, Ala
Endoscopic removal of mobile broncholiths with rigid and flexible bronchoscopic equipment is safe.
Thoracotomy with broncholithectomy is also safe and effective but is reserved for symptomatic
lesions that cannot be removed bronchoscopically. Calcified nodes in asymptomatic patients are not
an indication for intervention.
191 Descending necrotizing mediastinitis: A 10-year surgical experience in a single
institution
Ke-Cheng Chen, MD, Jin-Shing Chen, MD, PhD, Shuenn-Wen Kuo, MD, Pei-Ming Huang, MD,
Hsao-Hsun Hsu, MD, Jang-Ming Lee, MD, PhD, and Yung-Chie Lee, MD, PhD, Taipei, Taiwan
DNM is a life-threatening condition. Our multidisciplinary, minimally invasive surgical strategy,
mainly comprising a transcervical approach with or without VATS, successfully lowered the
mortality rate to 16.7%. Regarding the causative pathogens, Klebsiella pneumoniae uniquely
represents the most important and threatening pathogen for diabetic patients with DNM.
199 Use of novel autoantibody and cancer-related protein arrays for the detection of
esophageal adenocarcinoma in serum
Arman Kilic, BS, Matthew J. Schuchert, MD, James D. Luketich, MD, Rodney J. Landreneau, MD,
Anna E. Lokshin, PhD, William L. Bigbee, PhD, and Talal El-Hefnawy, MD, PhD, Pittsburgh, Pa
This study evaluated the feasibility of using novel autoantibody and cancer-related protein arrays to
identify potential biomarkers of esophageal adenocarcinoma in serum. When combined, the most
discriminative autoantibody and cancer-related protein that were identified were associated with
88.9% sensitivity and 100% specificity.
205 Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission
tomography as a significant predictor of survival after subsequent surgery in
multimodality treatment for patients with locally advanced esophageal
squamous cell carcinoma
Ichirou Higuchi, MD, Takushi Yasuda, MD, Masahiko Yano, MD, Yuichirou Doki, MD, Hiroshi
Miyata, MD, Mitsuaki Tatsumi, MD, Hironori Fukunaga, MD, Shuji Takiguchi, MD, Yoshiyuki
Fujiwara, MD, Jun Hatazawa, MD, and Morito Monden, MD, Osaka, Japan
Posttreatment positron emission tomography with fludeoxyglucose F 18 is a key modality in
evaluation of response to neoadjuvant therapy for advanced esophageal squamous cell cancer. A
posttreatment standardized uptake value less than 2.5 indicates histologic major response and predicts
good postoperative survival.
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